Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction—A Real-world Experience-Reference-Cited by-同舟云学术

Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction—A Real-world Experience

Published:2021-06-17 Issue:8 Volume:8 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Sandmann Lisa¹^ORCID,Deppe Julian²³,Beier Christoph¹,Ohlendorf Valerie¹,Schneider Julia¹,Wedemeyer Heiner¹⁴,Wedegärtner Felix²,Cornberg Markus¹⁴⁵,Maasoumy Benjamin¹⁴⁵

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

2. Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany

3. Patrida Medizinisches Versorgungszentrum, Hannover, Germany

4. German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany

5. Centre for Individualised Infection Medicine (CiiM), Helmholtz Centre for Infection Research, Hannover, Germany

Abstract

Abstract To achieve global hepatitis C virus (HCV) eradication, barriers prohibiting treatment access need to be overcome. We established a strategy to initiate antiviral therapy in patients with severe, refractory heroin addiction. All patients achieved sustained virological response. Outreach programs of hepatologists might be a reasonable way to overcome barriers to HCV treatment.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofab325/38684562/ofab325.pdf

Reference22 articles.

1. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review;Degenhardt;Lancet Glob Health,2017

2. Prevalence of hepatitis B, C, and D in Germany: results from a scoping review;Sperle;Front Public Health,2020

3. Clinical and patient-reported outcomes of direct-acting antivirals for the treatment of chronic hepatitis C among patients on opioid agonist treatment: a real-world prospective cohort study;Schulte;Open Forum Infect Dis,2020

4. Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: still a concern in clinical practice?;Christensen;Addiction,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Securing wider EU commitment to the elimination of hepatitis C virus;Liver International;2022-12-14

2. Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany;Journal of Viral Hepatitis;2022-05-05